ZA941237B - The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity - Google Patents

The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity

Info

Publication number
ZA941237B
ZA941237B ZA941237A ZA941237A ZA941237B ZA 941237 B ZA941237 B ZA 941237B ZA 941237 A ZA941237 A ZA 941237A ZA 941237 A ZA941237 A ZA 941237A ZA 941237 B ZA941237 B ZA 941237B
Authority
ZA
South Africa
Prior art keywords
helminth
loss
natural immunity
control
disease associated
Prior art date
Application number
ZA941237A
Other languages
English (en)
Inventor
Timothy Peter Rolph
Stuart John Andrews
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Publication of ZA941237B publication Critical patent/ZA941237B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA941237A 1993-02-24 1994-02-23 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity ZA941237B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303681A GB9303681D0 (en) 1993-02-24 1993-02-24 Vaccines

Publications (1)

Publication Number Publication Date
ZA941237B true ZA941237B (en) 1994-09-19

Family

ID=10730938

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941237A ZA941237B (en) 1993-02-24 1994-02-23 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity

Country Status (17)

Country Link
EP (1) EP0686041B1 (ja)
JP (1) JPH08506828A (ja)
AT (1) ATE152916T1 (ja)
AU (1) AU679494B2 (ja)
BG (1) BG61934B1 (ja)
CA (1) CA2155119A1 (ja)
CZ (1) CZ213895A3 (ja)
DE (1) DE69403197T2 (ja)
ES (1) ES2102836T3 (ja)
GB (1) GB9303681D0 (ja)
HU (1) HUT72919A (ja)
MX (1) MX9401384A (ja)
NO (1) NO953311L (ja)
NZ (1) NZ261598A (ja)
RU (1) RU2145876C1 (ja)
WO (1) WO1994019010A1 (ja)
ZA (1) ZA941237B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815674D0 (en) * 2008-08-28 2008-10-08 Moredun Res Inst Nematode vaccine
AU2020379734A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
WO2023114954A1 (en) 2021-12-17 2023-06-22 Genzyme Corporation Pyrazolopyrazine compounds as shp2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
ZW8893A1 (en) * 1992-07-21 1994-06-01 Pitman Moore Inc Vaccines

Also Published As

Publication number Publication date
BG61934B1 (bg) 1998-10-30
CZ213895A3 (en) 1996-03-13
HU9502467D0 (en) 1995-10-30
HUT72919A (en) 1996-06-28
NO953311L (no) 1995-10-19
CA2155119A1 (en) 1994-09-01
WO1994019010A1 (en) 1994-09-01
ES2102836T3 (es) 1997-08-01
NO953311D0 (no) 1995-08-23
AU679494B2 (en) 1997-07-03
BG99888A (bg) 1996-04-30
RU2145876C1 (ru) 2000-02-27
JPH08506828A (ja) 1996-07-23
EP0686041A1 (en) 1995-12-13
ATE152916T1 (de) 1997-05-15
EP0686041B1 (en) 1997-05-14
DE69403197D1 (de) 1997-06-19
NZ261598A (en) 1997-03-24
DE69403197T2 (de) 1997-08-28
GB9303681D0 (en) 1993-04-14
MX9401384A (es) 1994-08-31
AU6041594A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
ATE127345T1 (de) Stressproteine und verwendungen dafür.
PT851927E (pt) Compostos para imunoterapia e diagnostico de tuberculose
ES2030124T3 (es) Dispositivo para la aplicacion de implantes.
NO20015073L (no) Vaksiner
EP0024493A3 (en) Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
BR9610679A (pt) Antígenos de leishmania para uso na terapia e disgnose da leishmaniose
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
HU9502467D0 (en) The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity
ATE352315T1 (de) Neospora impstoff
ES2177535T3 (es) Vacunas contra protozoos intestinales.
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
PT603386E (pt) Imunizacao parenterica contra rotavirus
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
UA49145A (uk) Спосіб стандартизації моделювання проникної інфікованої травми заднього сегмента ока
TH44141A (th) การให้วัคซีนเข้าสู่ไข่เพื่อต่อต้านโรคบิด
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis